Professor Adam Timmis

Profile

ORCID iD: 0000-0003-1419-112X 

Adam Timmis graduated from Cambridge University and trained in cardiology at Massachussetts General and Guys Hospitals before taking up his present post. The rapid access chest pain clinic he pioneered changed UK practice by spawning a nationwide clinic network. He chaired NICE guideline groups on investigation of stable chest pain (2010) and management of angina (2011), was former Editor of Heart (2006-2013), is an executive member of the National Institute of Cardiovascular Outcomes Research (NICOR) and chairs the Academic Group of the Myocardial Ischaemia National Audit Process (MINAP). He is now an executive member of the Farr Institute and the founding Editor-in-Chief of the European Society of Cardiology’s journal of Quality of Care and Clinical Outcomes.

Research

Professor Adam Timmis’ collaborative research group straddles 4 major institutions (QMUL, UCL, LSHTM, Bristol U) and was a finalist in the prestigious BMJ award for "outstanding achievement in evidence based healthcare" (2009). The group’s research, which focuses on healthcare delivery as it affects cardiovascular outcomes, is closely aligned with the NHS transparency and quality initiatives. It started with local cardiovascular data collections in East London and now utilises linked electronic health records held by the National Institute of CV Outcomes Research and the Farr Institute, providing a national perspective on the patient journey through a range of cardiovascular phenotypes.

Publications

• Timmis A (2024). Data science from EuroHeart: a job in hand.

  
  

  DOI: 10.1093/eurheartj/ehae819

  
  

  QMRO:
• Timmis A, Aboyans V, Vardas P et al. (2024). European Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics.

  
  

  DOI: 10.1093/eurheartj/ehae466

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/100493
• Walli-Attaei M, Little M, Luengo-Fernandez R et al. (2024). Health-related quality of life and healthcare costs of symptoms and cardiovascular disease events in patients with atrial fibrillation: a longitudinal analysis of 27 countries from the EURObservational Research Programme on Atrial Fibrillation general long-term registry.

  
  

  DOI: 10.1093/europace/euae146

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/100549
• Walli-Attaei M, Luengo-Fernandez R, Gray A et al. (2023). Variations in the costs of atrial fibrillation: a longitudinal study across 27 European and Central Asian countries.

  
  

  DOI: 10.1093/eurheartj/ehad655.3032

  
  

  QMRO:
• Timmis A, Kazakiewicz D, Torbica A et al. (2023). Cardiovascular disease care and outcomes in West and South European countries.

  
  

  DOI: 10.1016/j.lanepe.2023.100718

  
  

  QMRO:
• Burger PM, Savarese G, Tromp J et al. (2023). Personalized lifetime prediction of survival and treatment benefit in patients with heart failure with reduced ejection fraction: The LIFE‐HF model.

  
  

  DOI: 10.1002/ejhf.3028

  
  

  QMRO:
• Luengo-Fernandez R, Walli-Attaei M, Gray A et al. (2023). Economic burden of cardiovascular diseases in the European Union: a population-based cost study.

  
  

  DOI: 10.1093/eurheartj/ehad583

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/90371
• Luengo-Fernandez R, Little M, Gray A et al. (2024). Cardiovascular disease burden due to productivity losses in European Society of Cardiology countries.

  
  

  DOI: 10.1093/ehjqcco/qcad031

  
  

  QMRO:
• Pennells L, Kaptoge S, Østergaard HB et al. (2023). SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe.

  
  

  DOI: 10.1093/eurheartj/ehad260

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/91428
• Timmis A, Kazakiewicz D, Townsend N et al. (2023). Global epidemiology of acute coronary syndromes.

  
  

  DOI: 10.1038/s41569-023-00884-0

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/88729

Collaborators

Internal

• Dr Mike Barnes (WHRI)
• Prof Steffen Petersen (WHRI)
• Dr John Robson (CEG)
  

External

• Prof Harry Hemingway (Farr Institute, London)
• Prof John Deanfield (NICOR)
• Prof Liam Smeeth (LSHTM)
• Prof Gene Feder (Bristol University)
• Dr Chris Gale (Leeds University)